137 related articles for article (PubMed ID: 10665781)
1. Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats.
Turull A; Queralt J
Immunopharmacology; 2000 Jan; 46(1):71-7. PubMed ID: 10665781
[TBL] [Abstract][Full Text] [Related]
2. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide.
Turull A; Queralt J
Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):27-37. PubMed ID: 11519792
[TBL] [Abstract][Full Text] [Related]
3. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
[TBL] [Abstract][Full Text] [Related]
4. Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats.
Turull N; Queralt J
Inflammation; 2000 Dec; 24(6):533-45. PubMed ID: 11128051
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
Ochi T; Goto T
J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
[TBL] [Abstract][Full Text] [Related]
7. Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis.
Heise G; Grabensee B; Schrör K; Heering P
Nephron; 1998 Oct; 80(2):220-6. PubMed ID: 9736824
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds.
Hiermann A; Schramm HW; Laufer S
Inflamm Res; 1998 Nov; 47(11):421-7. PubMed ID: 9865500
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of a selective cyclooxygenase-2 inhibitor, HN-56249: a novel compound exhibiting a marked preference for the human enzyme in intact cells.
Berg J; Fellier H; Christoph T; Kremminger P; Hartmann M; Blaschke H; Rovensky F; Towart R; Stimmeder D
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):363-72. PubMed ID: 10763850
[TBL] [Abstract][Full Text] [Related]
10. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of cyclooxygenase-2 with antisense oligodeoxynucleotide restricts induction of rat adjuvant-induced arthritis.
Yamada R; Sano H; Hla T; Hashiramoto A; Kawahito Y; Mukai S; Kohno M; Tsubouchi Y; Inoue M; Komatsu A; Inoue K; Kondo M
Biochem Biophys Res Commun; 2000 Mar; 269(2):415-21. PubMed ID: 10708568
[TBL] [Abstract][Full Text] [Related]
13. Effects of pentoxifylline and nabumetone on the serum levels of IL-1beta and TNFalpha in rats with adjuvant arthritis.
Silva JC; Rocha MF; Lima AA; Brito GA; de Menezes DB; Rao VS
Inflamm Res; 2000 Jan; 49(1):14-9. PubMed ID: 10778916
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of cyclooxygenase-2 (COX-2).
Talley JJ
Prog Med Chem; 1999; 36():201-34. PubMed ID: 10818674
[No Abstract] [Full Text] [Related]
15. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats.
Turull A; Piera C; Queralt J
Inflammation; 2001 Apr; 25(2):119-28. PubMed ID: 11321358
[TBL] [Abstract][Full Text] [Related]
17. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat.
Gilroy DW; Tomlinson A; Greenslade K; Seed MP; Willoughby DA
Inflammation; 1998 Oct; 22(5):509-19. PubMed ID: 9793797
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
20. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease.
Willoughby DA; Moore AR; Colville-Nash PR
Lancet; 2000 Feb; 355(9204):646-8. PubMed ID: 10696997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
